Inventor · disambiguated record
Michael Riis Hansen
Also filed as: HANSEN MICHAEL RIIS
5 granted patents·8 pending applications·0 citations·filing 2020–2024
60Inventor score
Files withJANSSEN BIOTECH INC13
Top patents by PatentIndex Score
13 records- 0179US12492256B2Methods and compositions for modulating beta chain mediated immunityJANSSEN BIOTECH INC·Filed 2024·Granted Dec 9, 2025·0 cites·28 claims
- 0275US2025043004A1Multi-specific immune targeting molecules and uses thereofJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 0375US2024424130A1Compositions and methods for modulating delta gamma chain mediated immunityJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 0470US11965024B2Methods and compositions for modulating beta chain mediated immunityJANSSEN BIOTECH INC·Filed 2021·Granted Apr 23, 2024·0 cites·34 claims
- 0565US12076413B2Compositions and methods for modulating delta gamma chain mediated immunityJANSSEN BIOTECH INC·Filed 2021·Granted Sep 3, 2024·0 cites·13 claims
- 0664US2025205280A1Methods and Compositions Comprising V beta 17 Bispecific T Cell Engagers and Bioengineered Virus Specific LymphocytesJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 0763US2022089737A1Multi-specific immune targeting molecules and uses thereofJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 0860US2025230254A1Biosynthetic bioparatopic or bispecific binding molecules with enhanced effector functionsJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 0960US2025011454A1Biosynthetic monovalent binding molecules with enhanced effector functionsJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 1060US2025092134A1Compositions and methods for the modulation of beta chain-mediated immunityJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 1158US12448449B2Immune targeting molecules and uses thereofJANSSEN BIOTECH INC·Filed 2021·Granted Oct 21, 2025·0 cites·5 claims
- 1256US11926667B2Bioengineered T cell mediated immunity, materials and other methods for modulating cluster of differentiation IV and/or VIIIJANSSEN BIOTECH INC·Filed 2021·Granted Mar 12, 2024·0 cites·21 claims
- 1356US2021214440A1Materials and methods for in vivo biological targetingJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Riis Hansen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →